LifeStance Health (LFST) Receivables - Net (2020 - 2026)

LifeStance Health (LFST) has reported Receivables - Net for 7 consecutive years, with $122.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables - Net fell 12.43% year-over-year to $122.9 million; the TTM figure through Mar 2026 stood at $122.9 million (down 12.43% YoY), while the FY2025 annual figure was $95.7 million, down 27.38% from the prior year.
• Receivables - Net advanced to $122.9 million in Q1 2026 per LFST's latest filing, from $95.7 million in the prior quarter.
• Across five years, Receivables - Net topped out at $175.9 million in Q1 2024 and bottomed at $95.0 million in Q1 2022.
• Historically, Receivables - Net has averaged $127.5 million across 5 years, with a median of $122.9 million in 2026.
• Annual changes were most pronounced in 2022 — Receivables - Net surged 66.04% — and 2025, when it slipped 27.38%.
• LifeStance Health's Receivables - Net stood at $100.9 million in 2022, then advanced by 24.33% to $125.4 million in 2023, then rose by 5.1% to $131.8 million in 2024, then retreated by 27.38% to $95.7 million in 2025, then gained by 28.43% to $122.9 million in 2026.
• Business Quant data shows LFST's Receivables - Net at $122.9 million in Q1 2026, $95.7 million in Q4 2025, and $121.1 million in Q3 2025.